Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:OABI NASDAQ:OPRX NASDAQ:TSSI NYSE:YEXT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOABIOmniAb$2.60+0.2%$1.75$1.22▼$2.73$375.71M0.07521,054 shs389,131 shsOPRXOptimizeRx$5.10+4.4%$6.16$4.57▼$22.25$95.86M1.19462,673 shs133,071 shsTSSITSS$13.32+6.2%$13.22$6.87▼$31.94$377.26M2.041.54 million shs721,462 shsYEXTYext$3.95+0.1%$3.92$3.29▼$9.20$393.93M1.142.58 million shs629,813 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOABIOmniAb+1.57%+0.39%+79.86%+43.89%+94.74%OPRXOptimizeRx+1.04%-1.81%-23.87%-37.76%-61.39%TSSITSS-3.39%+12.67%-16.90%+41.53%-2.11%YEXTYext+4.09%+10.23%+2.12%-29.30%-40.36%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOABIOmniAb$2.60+0.2%$1.75$1.22▼$2.73$375.71M0.07521,054 shs389,131 shsOPRXOptimizeRx$5.10+4.4%$6.16$4.57▼$22.25$95.86M1.19462,673 shs133,071 shsTSSITSS$13.32+6.2%$13.22$6.87▼$31.94$377.26M2.041.54 million shs721,462 shsYEXTYext$3.95+0.1%$3.92$3.29▼$9.20$393.93M1.142.58 million shs629,813 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOABIOmniAb+1.57%+0.39%+79.86%+43.89%+94.74%OPRXOptimizeRx+1.04%-1.81%-23.87%-37.76%-61.39%TSSITSS-3.39%+12.67%-16.90%+41.53%-2.11%YEXTYext+4.09%+10.23%+2.12%-29.30%-40.36%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOABIOmniAb 2.33Hold$3.0015.61% UpsideOPRXOptimizeRx 2.56Moderate Buy$13.43165.91% UpsideTSSITSS 2.50Moderate Buy$17.1728.51% UpsideYEXTYext 2.17Hold$7.5091.08% UpsideCurrent Analyst Ratings BreakdownLatest OPRX, OABI, TSSI, and YEXT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/18/2026OABIOmniAb Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/14/2026OPRXOptimizeRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/13/2026OPRXOptimizeRx UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$10.005/13/2026OPRXOptimizeRx Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$20.00 ➝ $11.005/13/2026OPRXOptimizeRx StephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$10.00 ➝ $7.005/13/2026OPRXOptimizeRx Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$17.00 ➝ $14.005/13/2026OPRXOptimizeRx B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$11.00 ➝ $10.005/11/2026TSSITSS Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C)5/8/2026TSSITSS Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$16.005/4/2026OABIOmniAb Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/4/2026OPRXOptimizeRx Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 5/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOABIOmniAb$28.94M12.98N/AN/A$1.81 per share1.43OPRXOptimizeRx$109.43M0.87$1.03 per share4.91$6.91 per share0.73TSSITSS$245.72M1.53$0.68 per share19.76$2.80 per share4.77YEXTYext$446.58M0.88$0.56 per share7.04$1.29 per share3.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOABIOmniAb-$64.78M-$0.46N/AN/AN/A-187.59%-20.31%-18.10%8/6/2026 (Estimated)OPRXOptimizeRx$5.13M$0.3514.438.28N/A6.37%10.86%7.93%8/6/2026 (Estimated)TSSITSS$15.12M$0.4927.19N/AN/A7.14%25.27%8.97%N/AYEXTYext$37.87M$0.0665.4311.54N/A8.48%29.61%7.59%6/2/2026 (Estimated)Latest OPRX, OABI, TSSI, and YEXT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/2/2026Q1 2027YEXTYext$0.13N/AN/AN/A$112.10 millionN/A5/12/2026Q1 2026OPRXOptimizeRx$0.01$0.14+$0.13-$0.03$18.74 million$19.84 million5/7/2026Q1 2026OABIOmniAb-$0.10-$0.06+$0.04-$0.06$5.60 million$14.43 million5/7/2026Q1 2026TSSITSS$0.04$0.08+$0.04$0.08N/A$55.35 million3/11/2026Q4 2025TSSITSSN/A$0.41N/A$0.41N/A$60.91 million3/9/2026Q4 2026YEXTYext$0.14$0.15+$0.01$0.03$114.21 million$112.00 million3/5/2026Q4 2025OPRXOptimizeRx$0.23$0.51+$0.28$0.26$30.92 million$32.24 million3/4/2026Q4 2025OABIOmniAb-$0.08-$0.11-$0.03-$0.11$9.00 million$8.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthOABIOmniAbN/AN/AN/AN/AN/AOPRXOptimizeRxN/AN/AN/AN/AN/ATSSITSSN/AN/AN/AN/AN/AYEXTYextN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioOABIOmniAbN/A4.804.80OPRXOptimizeRx0.165.375.37TSSITSS0.162.181.99YEXTYext0.611.071.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOABIOmniAb72.08%OPRXOptimizeRx76.47%TSSITSSN/AYEXTYext70.98%Insider OwnershipCompanyInsider OwnershipOABIOmniAb9.80%OPRXOptimizeRx5.60%TSSITSS18.94%YEXTYext5.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOABIOmniAb7144.78 million130.59 millionOptionableOPRXOptimizeRx10018.76 million17.71 millionOptionableTSSITSS7028.07 million22.76 millionN/AYEXTYext1,120100.11 million94.91 millionOptionableOPRX, OABI, TSSI, and YEXT HeadlinesRecent News About These CompaniesYext (YEXT) to Release Quarterly Earnings on TuesdayMay 26 at 2:04 AM | americanbankingnews.comYext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026May 19, 2026 | businesswire.comYext Opens Scout Visibility Intelligence to Partners with the Launch of MCP and APIMay 18, 2026 | businesswire.comWhy Is Yext Stock in Focus Right NowMay 8, 2026 | kalkinemedia.comKHow The Yext (YEXT) Story Is Shifting As Price Targets And Buyout Questions EvolveMay 7, 2026 | finance.yahoo.comYext (NYSE:YEXT) Receives Consensus Rating of "Hold" from AnalystsMay 7, 2026 | marketbeat.comDataParser Announces Support for Yext SocialMay 6, 2026 | globenewswire.comYext (NYSE:YEXT) Cut to Hold at Wall Street ZenMay 3, 2026 | marketbeat.comPopmenu Deepens Yext Integration to Power Real-Time Reputation ManagementMay 1, 2026 | qsrmagazine.comQPopmenu Partners with Yext to Help Restaurants Easily Manage Their Online Reputation Across 70+ PlatformsApril 30, 2026 | prnewswire.comYext Stock Forecast: Why Is Yext in Focus Right NowApril 26, 2026 | kalkinemedia.comK10 Oversold Tech Stocks to Buy According to AnalystsApril 23, 2026 | insidermonkey.comIs Yext (YEXT) One of the Oversold Tech Stocks to Buy According to Analysts?April 23, 2026 | uk.finance.yahoo.comDataParser Announces Support for Yext RelateApril 22, 2026 | globenewswire.comHow The Yext (YEXT) Story Is Shifting As Scout Progress Meets Buyout UncertaintyApril 19, 2026 | finance.yahoo.comYext (NYSE:YEXT) CAO Allan Tang Sells 10,000 SharesApril 18, 2026 | insidertrades.comIs Yext shaking SaaS stocks on NYSE Composite market right now?April 18, 2026 | kalkinemedia.comKYext Insider Makes Notable Move With Fresh Stock SaleApril 17, 2026 | tipranks.comWhy Yext (YEXT) Could be a Top Performing Software Penny StockApril 11, 2026 | finance.yahoo.com5 Best Software Penny Stocks to Buy NowApril 10, 2026 | insidermonkey.comMajor Yext Stake Dumped by Key Investor in High-Profile Market MoveApril 6, 2026 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOPRX, OABI, TSSI, and YEXT Company DescriptionsOmniAb NASDAQ:OABI$2.60 +0.01 (+0.19%) As of 02:19 PM Eastern This is a fair market value price provided by Massive. Learn more.OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.OptimizeRx NASDAQ:OPRX$5.10 +0.22 (+4.41%) As of 02:18 PM Eastern This is a fair market value price provided by Massive. Learn more.OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.TSS NASDAQ:TSSI$13.32 +0.78 (+6.19%) As of 02:19 PM Eastern This is a fair market value price provided by Massive. Learn more.TSS, Inc. offers planning, design, engineering, construction management, commissioning and maintenance services. It provides these services primarily for specialized facilities such as data centers, communications rooms, call centers, laboratories, trading floors, network operations centers, medical facilities and similar environments. TSS Inc., formerly known as Fortress International Group, Inc., is based in Columbia, United States.Yext NYSE:YEXT$3.94 +0.01 (+0.13%) As of 02:18 PM Eastern This is a fair market value price provided by Massive. Learn more.Yext, Inc. organizes business facts to provide answers to consumer questions in North America and internationally. It operates Yext platform, a cloud-based platform that allows its customers to offer answers to consumer questions, to control the facts about their businesses and the content of their landing pages, and to manage their consumer reviews; and provides customers to update their information and content through its publisher network of maps, apps, search engines, intelligent GPS systems, digital assistants, vertical directories, and social networks, as well as professional services. The company's platform also enables its customers to centralize, control and manage data fields, including store information comprising name, address, phone number, and holiday hours; professional information, such as headshot, specialties, and education; job information consists of title and description; FAQs and other information. It serves various industries, such as healthcare, hospitality, food services, retail, and financial services. Yext, Inc. was incorporated in 2006 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas IREN Is Flipping the Switch from Bitcoin to AI This Quantum Computing Stock May Be Closer to a Breakout Than You Think Microsoft Is Spending Billions on AI, But Investors Aren’t Buying It If the Market Rally Stalls, This ETF Can Insulate Portfolios RTX Is Set to Revolutionize Munitions Manufacturing Is Co-Diagnostics National Security’s Next Diagnostic Pick? Semtech’s Explosive Rally May Only Be Getting Started The Food Delivery War Just Entered Its Final Phase Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
